VOR — VOR BIOPHARMA INC

Ownership history in Virtu Financial LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which Virtu Financial LLC reported a position in VOR BIOPHARMA INC (VOR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2025 Q2)
Avg. % of fund
0.01%
First filed
2022 Q2
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 8,104 -267,808 -97.1% 0.02% $395K $48.72
2025 Q2 ADDED 275,912 +221,442 +406.5% 0.02% $447K $32.40
2024 Q4 ADDED 54,470 +42,100 +340.3% 0.00% $60K $22.20
2024 Q2 ADDED 12,370 +605 +5.1% 0.00% $12K $20.00
2023 Q2 REDUCED 11,765 -3,797 -24.4% 0.00% $36K $61.80
2023 Q1 ADDED 15,562 +3,310 +27.0% 0.01% $84K $107.60
2022 Q2 INITIATED 12,252 — — 0.01% $61K $99.40
% of Fund (quarterly)    VOR price (monthly, adj. close)

Other funds also holding VOR

As of 2025 Q4 — sorted by position size

FCPM III SERVICES B.V. 6.2% GREAT POINT PARTNERS LLC 3Y 7Y 5.81% VR Adviser, LLC 3Y 1.26% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.04% Frazier Life Sciences Management, L.P. 3Y 0.89% FINDELL CAPITAL MANAGEMENT LLC 0.87% Caligan Partners LP 3Y 0.82% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.72% Paradigm Biocapital Advisors LP 3Y 0.58% Sarissa Capital Management LP 3Y 7Y 0.15%
← Back to Virtu Financial LLC Holdings